Subtitle
Breast and chest wall treatment with pencil beam scanning at the proton therapy center in Prague
Subtitle
Breast and chest wall treatment with pencil beam scanning at the proton therapy center in Prague
Case Time
2018
Please connect to access this resource and get a more personalized Campus experience
No account yet? Request access
Executive summary
Body
The Proton Therapy Centre in Prague (PTC) is a leading global health care facility and one of the most advanced proton therapy providers in Europe. The centre is prepared to provide treatment for 2500 patients a year, with 4 treatment rooms equipped with state-of-the-art active scanning techniques.
The clinical team under the leadership of Vladimír Vondráček, MSc, Head of Medical Physics, has developed a comprehensive program to treat patients suffering from breast cancer.
Key content topics
Top cancer treatments
Guest speakers
Vladimir
Vondracek
Head of Medical Physics
Proton Therapy Center Czech
Related contents
Proton Therapy Publication
October 2024
Proton therapy for breast cancer: Reducing toxicity.
Proton Therapy Publication
September 2024
PTCOG international survey of practice patterns and trends in utilization of proton therapy for breast cancer.
Proton Therapy Publication
September 2024
Reducing Radiation Dermatitis for PBS Proton Therapy Breast Cancer Patients Using SpotDelete.
Proton Therapy Publication
September 2024
Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial.
Proton Therapy Publication
October 2024
Revision Surgeries After Proton vs Photon Postmastectomy Radiation Therapy in Prepectoral Implant-Based Breast Reconstruction.
Proton Therapy Publication
June 2024
Dosimetric Correlation of Acute Radiation Dermatitis in Patients With Breast Cancer Undergoing Hypofractionated Proton Beam Therapy Using Pencil Beam Scanning.
Proton Therapy Publication
July 2024
Proton therapy reduces the effective dose to immune cells in breast cancer patients.
Proton Therapy Publication
May 2023
Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.